Evidence map›Paper›PMID 26752416›Full record

Trial reportAddiction biology2017

Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.

Robert Miranda, Hayley Treloar, Alexander Blanchard, Alicia Justus, Peter M Monti, Thomas Chun, Robert Swift, Jennifer W Tidey, Chad J Gwaltney

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Addiction biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 6 pooled it
8.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 6 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pharmacotherapies for cannabis use disorder.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pharmacotherapies for cannabis dependence.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018-2023: Current Status, Best Practices, and Opportunities for Advancing the Science.Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
    Pooled it
  7. Trial
  8. Day-level shifts in social contexts during youth cannabis use treatment.Journal of consulting and clinical psychology · 2021
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Dynamic associations between cannabis use and sleep in adolescents and young adults during a cannabis intervention trial.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2025
    Article
  17. Cannabis Use in Adolescents.Delaware journal of public health · 2025
    Article
  18. Article
  19. Review
  20. Cannabis use disorder: from neurobiology to treatment.The Journal of clinical investigation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert MirandaBrown University, Providence, RI, USA.
Hayley TreloarBrown University, Providence, RI, USA.
Alexander BlanchardBrown University, Providence, RI, USA.
Alicia JustusBrown University, Providence, RI, USA.
Peter M MontiBrown University, Providence, RI, USA.
Thomas ChunBrown University, Providence, RI, USA.
Robert SwiftBrown University, Providence, RI, USA.
Jennifer W TideyBrown University, Providence, RI, USA.
Chad J GwaltneyBrown University, Providence, RI, USA.
Brown University · US

Funding

Advancing a Bio-Psycho-Social Alcohol Treatment Research and Mentoring ProgramK05AA019681 · NIAAA · BROWN UNIVERSITY · PI MONTI, PETER M. · 2010 to 2014
$1.2M
Biobehavioral effects of topiramate on cannabis-related outcomes in adolescentsR01DA026778 · NIDA · BROWN UNIVERSITY · PI MIRANDA, ROBERT · 2009 to 2010
$1.1M
Novel Approaches to Understanding How Alcohol Pathology Develops in AdolescentsK23AA024808 · NIAAA · BROWN UNIVERSITY · PI TRELOAR PADOVANO, HAYLEY · 2017 to 2021
$973k
NIAAA NIH HHS K05 AA019681NIAAA NIH HHS K23 AA024808NIDA NIH HHS R01 DA026778
6 · The paper itself

Abstract

Cannabis misuse accounts for nearly all of the substance abuse treatment admissions among youth in the United States. Most youth do not experience sustained benefit from existing psychosocial treatments; however, medication development research for treating adolescent cannabis misuse is almost nonexistent. We conducted a double-blind, placebo-controlled, pilot study to test the potential efficacy of topiramate plus motivational enhancement therapy (MET) for treating cannabis use among adolescents. Sixty-six heavy cannabis users, ages 15 to 24 years, were randomized to one of two 6-week treatment conditions: topiramate plus MET or placebo plus MET. Topiramate was titrated over 4 weeks then stabilized at 200 mg/day for 2 weeks. MET was delivered biweekly for a total of three sessions. Only 48 percent of youths randomized to topiramate completed the 6-week trial (n = 19), compared with 77 percent of youths in the placebo condition (n = 20). Adverse medication side effects were the most common reason for withdrawal among participants in the topiramate group. Latent growth models showed that topiramate was superior to placebo for reducing the number of grams smoked per use day, but it did not improve abstinence rates. The same pattern of results was found when values for missing outcomes were imputed. We show that topiramate combined with MET demonstrated efficacy for reducing how much cannabis adolescents smoked when they used but did not affect abstinence rates. The magnitude of this effect was modest, however, and topiramate was poorly tolerated by youths, which calls into question the clinical importance of these findings.

Indexed as

AdolescentAdultDouble-Blind MethodFeasibility StudiesFeedback, PsychologicalFemaleFructoseHumansMaleMarijuana AbuseMotivational InterviewingNeuroprotective AgentsPilot ProjectsTopiramateTreatment OutcomeYoung AdultFructoseNeuroprotective AgentsTopiramateadolescentscannabis use disordermotivational enhancement therapytopiramate

Identifiers

PMID26752416
PMCPMC4940362
OpenAlexW2223090268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.